We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Teva Loses Patent Challenge For Glaxo's Zofran

Law360 (August 23, 2004, 12:00 AM EDT) -- A federal judge has upheld the validity of two key method-of-use patents for GlaxoSmithKline’s anti-nausea drug Zofran (ondansetron), dealing a blow to challenger Teva Pharmaceuticals.

In his ruling, U.S. Judge Gregory...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.